INTERACT Supports Updated NCCN Guidelines that Expand Access to Appropriate Hereditary Cancer Genetic Testing for Patients with Colorectal, Endometrial, and Gastric Cancers

SAN DIEGO, Oct. 17, 2024 /PRNewswire/ — The Inter-Organization Cancer Genetics Clinical Evidence Coalition (INTERACT) applauds the National Comprehensive Cancer Network (NCCN) for recent updates to its Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric practice guidelines that expand access to hereditary cancer genetic testing for individuals and their families impacted by colorectal, endometrial and gastric cancers.